Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OVID | AMGN | BMY | GILD | VRTX |
| Company | Ovid Therapeutics Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 1.1300 | 333.93 | 49.41 | 83.37 | 483.78 |
| High | 1.1500 | 339.00 | 50.18 | 84.52 | 483.78 |
| Low | 1.0300 | 331.00 | 48.78 | 82.76 | 476.06 |
| Last | 1.1000 | 334.12 | 49.82 | 84.16 | 477.52 |
| Change | -0.0200 | +1.32 | +0.33 | +1.11 | -3.74 |
| % Change | -1.79% | +0.40% | +0.67% | +1.34% | -0.78% |
| Volume | 153,044 | 752,940 | 4,069,406 | 5,961,224 | 435,065 |
| 20-Day Average Volume | 193,151 | 1,702,390 | 8,348,056 | 6,242,152 | 955,707 |
| Previous Close | 1.1200 | 332.80 | 49.49 | 83.05 | 481.26 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.1555 | 329.45 | 49.08 | 79.66 | 480.42 |
| 20-Day Raw Stochastic | 35.29% | 90.82% | 82.02% | 95.34% | 41.66% |
| 20-Day Relative Strength | 45.56% | 58.23% | 58.66% | 72.80% | 48.83% |
| Weighted Alpha | -9.20 | +27.59 | -8.60 | +19.25 | +33.25 |
| Today's Opinion | 64% Sell | 96% Buy | 72% Buy | 88% Buy | 40% Buy |
| Previous Opinion | 64% Sell | 88% Buy | 72% Buy | 88% Buy | 56% Buy |
| Last Month's Opinion | 72% Sell | 72% Buy | 24% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.57% since 09/11/24 | +2.10% since 09/11/24 | +3.02% since 09/11/24 | +4.30% since 09/11/24 | +0.51% since 09/11/24 |
| Low | 1.0600 on 09/18/24 | 326.41 on 09/12/24 | 47.76 on 09/12/24 | 81.57 on 09/13/24 | 468.46 on 09/12/24 |
| High | 1.2000 on 09/17/24 | 338.72 on 09/18/24 | 50.41 on 09/17/24 | 84.89 on 09/12/24 | 490.15 on 09/16/24 |
| 1-Month | |||||
| %Chg | -4.42% since 08/16/24 | +4.81% since 08/16/24 | +1.41% since 08/16/24 | +14.42% since 08/16/24 | -0.04% since 08/16/24 |
| Low | 0.9600 on 09/06/24 | 319.00 on 09/06/24 | 46.88 on 08/22/24 | 73.27 on 08/19/24 | 460.69 on 09/11/24 |
| High | 1.3000 on 08/29/24 | 338.72 on 09/18/24 | 50.75 on 09/04/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 |
| 3-Month | |||||
| %Chg | +37.07% since 06/18/24 | +10.10% since 06/18/24 | +22.65% since 06/18/24 | +33.68% since 06/18/24 | +2.12% since 06/18/24 |
| Low | 0.6800 on 06/26/24 | 303.55 on 06/20/24 | 39.35 on 07/05/24 | 64.86 on 06/20/24 | 458.04 on 08/13/24 |
| High | 1.3000 on 08/29/24 | 346.85 on 07/25/24 | 51.19 on 07/29/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 |
| 6-Month | |||||
| %Chg | -60.44% since 03/18/24 | +24.37% since 03/18/24 | -2.98% since 03/18/24 | +15.23% since 03/18/24 | +15.99% since 03/18/24 |
| Low | 0.6800 on 06/26/24 | 260.68 on 04/19/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 |
| High | 3.4500 on 04/30/24 | 346.85 on 07/25/24 | 54.47 on 03/28/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 79,458 | 178,525,568 | 100,321,184 | 103,468,096 | 124,190,592 |
| Shares Outstanding, K | 70,945 | 536,435 | 2,027,100 | 1,245,853 | 258,053 |
| Annual Sales | 390,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -52,340,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 170,000 | 8,388,000,000 | 12,201,000,000 | 6,954,000,000 | 2,645,600,000 |
| Last Quarter Net Income | 8,520,000 | 746,000,000 | 1,680,000,000 | 1,614,000,000 | -3,593,600,000 |
| 60-Month Beta | 0.42 | 0.61 | 0.46 | 0.18 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.12 on 08/13/24 | 4.97 on 08/06/24 | 2.07 on 07/26/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 |
| Latest Earnings Date | 11/01/24 | 10/29/24 | 10/31/24 | 11/05/24 | 11/04/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.600 on 07/05/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 10/04/24 | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.02 | 36.49 | 17.69 | 0.00 |